论文信息 - Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up - 字舞流文

Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up

D. Taverna | F. Novelli | M. Clerico | D. Horáková | S. D. De Mercanti | E. Cocco | M. Habek | I. Adamec | S. Rolla | A. Maglione | P. Annovazzi | A. Vladic | V. Bardina